14/11/2024
|
High conviction: "Decent recovery with a relief on asset quality" – Outperform (TP Bt21)
|
13/11/2024
|
Earnings brief: "3Q24: Miss on ECL, loan growth, fee income" – Outperform (TP Bt18)
|
13/08/2024
|
Company update: "Slash TP on rising asset quality risk" – Outperform (TP Bt17)
|
09/08/2024
|
Earnings brief: "2Q24: Rising NPLs & credit cost as expected" – Outperform (TP Bt25)
|
17/05/2024
|
Company update: "Good earnings growth with upside on dividend" – Outperform (TP Bt27)
|
08/05/2024
|
Earnings brief: "1Q24: Slight beat on NIM" – Outperform (TP Bt27)
|
06/03/2024
|
Company update: "Solid earnings recovery ahead" – Outperform (TP Bt27)
|
29/02/2024
|
Earnings brief: "4Q23: Big B/S cleanup as expected" – Outperform (TP27)
|
27/11/2023
|
Company update: "Strongest 2024F earnings among peers" – Outperform (TP Bt26)
|
07/11/2023
|
Earnings brief: "3Q23: Beat on ECL and NIM; Upgrade" – Upgrade to Outperform (TP Bt25)
|
22/08/2023
|
Company update: "B/S cleanup, loan growth slowing" – Neutral (TP Bt24)
|
11/08/2023
|
Earnongs brief:
"2Q23: In line"
–
Neutral (TP Bt26)
|
25/05/2023
|
Company update: "Slight cut in credit cost and NPL target" –
Neutral (TP Bt26)
|
10/05/2023
|
Earnings brief: "1Q23: Slight beat on opex"
–
Upgrade to Neutral (TP Bt25)
|
28/02/2023
|
Company update: "Worse-than-expected 2023 guidance" –
Downgrade to Underperform (TP Bt25)
|
20/02/2023
|
Earnings brief: "4Q22: In line; credit cost at a new high" – Neutral (TP Bt30)
|
08/02/2023
|
Company update: "Preview 4Q22: Up YoY, down QoQ" – Neutral (TP Bt30)
|
17/11/2022
|
Company update: "Raised credit cost guidance again" – Downgrade to Neutral (TP Bt30)
|
10/11/2022
|
Earnings brief: "3Q22: Missed on provisions" – Outperform (TP Bt32)
|
18/08/2022
|
Company update: "Raised credit cost guidance" - Outperform (TP Bt36)
|
11/08/2022
|
Earnings brief: "2Q22: Stronger NII offset by provision hike" – Outperform (TP Bt42)
|
20/05/2022
|
Company update: "Continued good growth ahead" – Outperform (TP Bt42)
|
12/05/2022
|
Earnings brief: "1Q22: Decent growth, as expected" – Outperform (TP Bt42)
|
22/02/2022
|
Earnings brief: "4Q21: In line; upgrade on share price weakness" – Upgrade to Outperform (TP Bt42)
|
19/11/2021
|
Company update: "Top line recovery but rising cost in 4Q21" – Neutral (TP Bt42)
|
16/11/2021
|
Earnings brief: "3Q21: Overall pretty much in line" – Neutral (TP Bt42)
|
24/08/2021
|
Company update: "Toning down topline growth target" – Neutral (TP Bt42)
|
16/08/2021
|
Earnings brief: "2Q21: Slight miss; TP cut" – Neutral (TP Bt42)
|
15/06/2021
|
Initiate coverage: "Solid growth but unattractive valuation" – Neutral (TP Bt45)
|
|
|
|
|
FOLLOW US
SCB's Facbook INVX's Twitter